Prostate Cancer Susceptibility Candidate (PRAC) Peptide
PRAC
Reactivity: Mammalian
Host: Synthetic
BP, WB, IHC
-
- Target See all PRAC products
- PRAC (Prostate Cancer Susceptibility Candidate (PRAC))
- Peptide Type
- Synthetic
- Origin
- Mammalian
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Sequence
- DQGPAHLTTS KSAFLSNKKT STLKHLLGET RSDGSACNSG ISGGRGRKIP
- Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of PRAC antibody,
Alternative Names: PRAC control peptide, PRAC antibody Blocking Peptide, Anti-PRAC Blocking Peptide, prostate cancer susceptibility candidate Blocking Peptide, C17orf92 Blocking Peptide, MGC32520 Blocking Peptide
-
-
- Application Notes
- Optimal conditions should be determined by the investigator
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Handling Advice
- Avoid repeated freeze/thaw cycles.
- Storage
- -20 °C
- Storage Comment
- Store at -20 °C long term.
-
- Target
- PRAC (Prostate Cancer Susceptibility Candidate (PRAC))
- Background
- This gene is reported to be specifically expressed in prostate, rectum and distal colon. Sequence analysis suggests that it may play a regulatory role in the nucleus.
- Molecular Weight
- 6 kDa
-
You are here:
